Evidence-Based Medicine Guidelines
Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism
Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Direct Thrombin Inhibitors or Oral Factor Xa Inhibitors for the Treatment of Pulmonary Embolism." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458533/all/Oral_direct_thrombin_inhibitors_or_oral_factor_Xa_inhibitors_for_the_treatment_of_pulmonary_embolism.
Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/458533/all/Oral_direct_thrombin_inhibitors_or_oral_factor_Xa_inhibitors_for_the_treatment_of_pulmonary_embolism. Accessed March 30, 2023.
Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/458533/all/Oral_direct_thrombin_inhibitors_or_oral_factor_Xa_inhibitors_for_the_treatment_of_pulmonary_embolism
Oral Direct Thrombin Inhibitors or Oral Factor Xa Inhibitors for the Treatment of Pulmonary Embolism [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458533/all/Oral_direct_thrombin_inhibitors_or_oral_factor_Xa_inhibitors_for_the_treatment_of_pulmonary_embolism.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism
ID - 458533
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458533/all/Oral_direct_thrombin_inhibitors_or_oral_factor_Xa_inhibitors_for_the_treatment_of_pulmonary_embolism
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
